3498 related articles for article (PubMed ID: 7490469)
21. T311--an anti-tyrosinase monoclonal antibody for the detection of melanocytic lesions in paraffin embedded tissues.
Jungbluth AA; Iversen K; Coplan K; Kolb D; Stockert E; Chen YT; Old LJ; Busam K
Pathol Res Pract; 2000; 196(4):235-42. PubMed ID: 10782467
[TBL] [Abstract][Full Text] [Related]
22. Identification of a tyrosinase epitope recognized by HLA-A24-restricted, tumor-infiltrating lymphocytes.
Kang X; Kawakami Y; el-Gamil M; Wang R; Sakaguchi K; Yannelli JR; Appella E; Rosenberg SA; Robbins PF
J Immunol; 1995 Aug; 155(3):1343-8. PubMed ID: 7543520
[TBL] [Abstract][Full Text] [Related]
23. Proteomic scan for tyrosinase peptide antigenic pattern in vitiligo and melanoma: role of sequence similarity and HLA-DR1 affinity.
Lucchese A; Willers J; Mittelman A; Kanduc D; Dummer R
J Immunol; 2005 Nov; 175(10):7009-20. PubMed ID: 16272362
[TBL] [Abstract][Full Text] [Related]
24. Human melanoma patients recognize an HLA-A1-restricted CTL epitope from tyrosinase containing two cysteine residues: implications for tumor vaccine development.
Kittlesen DJ; Thompson LW; Gulden PH; Skipper JC; Colella TA; Shabanowitz J; Hunt DF; Engelhard VH; Slingluff CL
J Immunol; 1998 Mar; 160(5):2099-106. PubMed ID: 9498746
[TBL] [Abstract][Full Text] [Related]
25. Monoclonal antibody directed against Neospora caninum tachyzoite carbohydrate epitope reacts specifically with apical complex-associated sialylated beta tubulin.
Srinivasan S; Baszler T; Vonlaufen N; Leepin A; Sanderson SJ; Wastling JM; Hemphill A
J Parasitol; 2006 Dec; 92(6):1235-43. PubMed ID: 17304800
[TBL] [Abstract][Full Text] [Related]
26. Immunoelectron microscopic demonstration of human melanosome associated antigens (HMSA) on melanoma cells: comparison with tyrosinase distribution.
Akutsu Y; Jimbow K
J Invest Dermatol; 1988 Feb; 90(2):179-84. PubMed ID: 3123559
[TBL] [Abstract][Full Text] [Related]
27. High-molecular-weight forms of tyrosinase and the tyrosinase-related proteins: evidence for a melanogenic complex.
Orlow SJ; Zhou BK; Chakraborty AK; Drucker M; Pifko-Hirst S; Pawelek JM
J Invest Dermatol; 1994 Aug; 103(2):196-201. PubMed ID: 8040609
[TBL] [Abstract][Full Text] [Related]
28. Cotransfection of genes encoding human tyrosinase and tyrosinase-related protein-1 prevents melanocyte death and enhances melanin pigmentation and gene expression of Lamp-1.
Luo D; Chen H; Jimbow K
Exp Cell Res; 1994 Jul; 213(1):231-41. PubMed ID: 8020595
[TBL] [Abstract][Full Text] [Related]
29. Quantitative analysis of tyrosinase and tyrosinase-related protein-2 mRNA from melanoma cells in blood by real-time polymerase chain reaction.
Johansson M; Arstrand K; Håkansson A; Lindholm C; Kågedal B
Melanoma Res; 2000 Jun; 10(3):213-22. PubMed ID: 10890374
[TBL] [Abstract][Full Text] [Related]
30. Subcellular distribution of tyrosinase and tyrosinase-related protein-1: implications for melanosomal biogenesis.
Orlow SJ; Boissy RE; Moran DJ; Pifko-Hirst S
J Invest Dermatol; 1993 Jan; 100(1):55-64. PubMed ID: 8423398
[TBL] [Abstract][Full Text] [Related]
31. Identification of epitopes on tyrosinase which are recognized by autoantibodies from patients with vitiligo.
Kemp EH; Waterman EA; Gawkrodger DJ; Watson PF; Weetman AP
J Invest Dermatol; 1999 Aug; 113(2):267-71. PubMed ID: 10469315
[TBL] [Abstract][Full Text] [Related]
32. Tyrosinase immunoreactivity in fine-needle aspiration samples of metastatic malignant melanoma.
Fetsch PA; Riker AI; Marincola FM; Abati A
Cancer; 2000 Aug; 90(4):252-7. PubMed ID: 10966567
[TBL] [Abstract][Full Text] [Related]
33. A tyrosinase nonapeptide presented by HLA-B44 is recognized on a human melanoma by autologous cytolytic T lymphocytes.
Brichard VG; Herman J; Van Pel A; Wildmann C; Gaugler B; Wölfel T; Boon T; Lethé B
Eur J Immunol; 1996 Jan; 26(1):224-30. PubMed ID: 8566071
[TBL] [Abstract][Full Text] [Related]
34. Optimization of the tyrosinase mRNA probe to detect circulating melanocytes with reverse transcription and polymerase chain reaction.
Carrillo E; Marchal JA; Prados J; Melguizo C; Vélez C; Arena N; Alvarez L; Serrano S; Aránega A
Cell Mol Biol (Noisy-le-grand); 1998 Dec; 44(8):1247-52. PubMed ID: 9874512
[TBL] [Abstract][Full Text] [Related]
35. A sensitive tyrosinase method for human skin.
Wittbjer A; Odh G; Rosengren E; Rorsman H
Acta Derm Venereol; 1991; 71(5):399-402. PubMed ID: 1684467
[TBL] [Abstract][Full Text] [Related]
36. Autoantibodies to tyrosinase-related protein-1 detected in the sera of vitiligo patients using a quantitative radiobinding assay.
Kemp EH; Waterman EA; Gawkrodger DJ; Watson PF; Weetman AP
Br J Dermatol; 1998 Nov; 139(5):798-805. PubMed ID: 9892944
[TBL] [Abstract][Full Text] [Related]
37. A novel hydrosoluble near-infrared fluorescent probe for specifically monitoring tyrosinase and application in a mouse model.
Zhang J; Li Z; Tian X; Ding N
Chem Commun (Camb); 2019 Aug; 55(64):9463-9466. PubMed ID: 31328200
[TBL] [Abstract][Full Text] [Related]
38. Molecular characterization of a human tyrosinase-related-protein-2 cDNA. Patterns of expression in melanocytic cells.
Bouchard B; Del Marmol V; Jackson IJ; Cherif D; Dubertret L
Eur J Biochem; 1994 Jan; 219(1-2):127-34. PubMed ID: 8306979
[TBL] [Abstract][Full Text] [Related]
39. Characterization of structural properties for morphological differentiation of melanosomes: I. Purification of tyrosinase by tyrosine affinity chromatography and its characterization in B16 and Harding Passey melanomas.
Jimbow K; Jimbow M; Chiba M
J Invest Dermatol; 1981 Aug; 77(2):213-8. PubMed ID: 6792293
[TBL] [Abstract][Full Text] [Related]
40. The effect of antisense tyrosinase-related protein 1 on melanocytes and malignant melanoma cells.
Li CY; Gao TW; Wang G; Han ZY; Shen Z; Li TH; Liu YF
Br J Dermatol; 2004 Jun; 150(6):1081-90. PubMed ID: 15214892
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
